Cargando…

Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome

Short-chain fatty acids (SCFAs) correlate with colonic transit time (CTT) and may influence irritable bowel syndrome (IBS) pathophysiology. However, the clinical significance of fecal SCFAs, relationships between SCFAs and other metabolites (bile acids [BAs]), and real-time diet effects on SCFAs in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waseem, Mohammed Rayyan, Shin, Andrea, Siwiec, Robert, James-Stevenson, Toyia, Bohm, Matthew, Rogers, Nicholas, Wo, John, Waseem, Lina, Gupta, Anita, Jarrett, Megan, Kadariya, Jhalka, Xu, Huiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875959/ https://www.ncbi.nlm.nih.gov/pubmed/36227781 http://dx.doi.org/10.14309/ctg.0000000000000541

Ejemplares similares

2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)

2073: Fecal bile acids, fecal short-chain fatty acids and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Use of Sacral Nerve Stimulation for the Treatment of Overlapping Constipation and Fecal Incontinence
por: Sreepati, Gouri, et al.
Publicado: (2017)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease
por: Blake, Amanda B., et al.
Publicado: (2019)

Long‐term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogs
por: Manchester, Alison C., et al.
Publicado: (2019)

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014)

Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
por: Acosta, Andrés, et al.
Publicado: (2016)

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
por: Ahmed, Iftikhar, et al.
Publicado: (2013)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)

In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota
por: Martin, Glynn, et al.
Publicado: (2018)

Developmental Patterns of Fecal Bile Acids in Healthy Neonates and Children
por: Xiong, Jing-Jing, et al.
Publicado: (2021)

Altered fecal bile acid composition in active ulcerative colitis
por: Sommersberger, Stefanie, et al.
Publicado: (2023)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients
por: Sun, Qing Hua, et al.
Publicado: (2021)

Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation
por: Marclay, Margaux, et al.
Publicado: (2022)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

ISOLATED FECAL MICROORGANISMS CAPABLE OF 7 α-DEHYDROXYLATING BILE ACIDS
por: Gustafsson, Bengt E., et al.
Publicado: (1966)

Interactions between fecal bacteria, bile acids and components of tomato pomace
por: Dziedzic, Krzysztof, et al.
Publicado: (2018)

Evaluation of gut dysbiosis using serum and fecal bile acid profiles
por: Monma, Tadakuni, et al.
Publicado: (2022)

A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis
por: Vaughn, Byron P, et al.
Publicado: (2019)

Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis
por: Sun, Qinghua, et al.
Publicado: (2019)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome
por: Zhan, Kai, et al.
Publicado: (2020)

Concentrations of Fecal Bile Acids in Participants with Functional Gut Disorders and Healthy Controls
por: James, Shanalee C., et al.
Publicado: (2021)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans
por: Bustamante, Jessica-Miranda, et al.
Publicado: (2022)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME
por: Pujo, J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kd0n09u8a233ukiea052auoqrb